ロード中...
Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report
BACKGROUND: Primary myelofibrosis is a myeloproliferative disorder characterized by bone marrow fibrosis, abnormal cytokine expression, splenomegaly and anemia. The activation of JAK2 and the increased levels of circulating proinflammatory cytokines seem to play an important role in the pathogenesis...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3515333/ https://ncbi.nlm.nih.gov/pubmed/23039051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-5-552 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|